δ-
Aminolevulinic acid (ALA)-induced
porphyrin accumulation is widely used in the treatment of
cancer, as
photodynamic therapy. To clarify the mechanisms of the
tumor-preferential accumulation of
protoporphyrin, we examined the effect of the expression of
heme-biosynthetic and -degradative
enzymes on the ALA-induced accumulation of
protoporphyrin as well as photodamage. The transient expression of
heme-biosynthetic
enzymes in HeLa cells caused variations of the ALA-induced accumulation of
protoporphyrin. When ALA-treated cells were exposed to white light, the extent of photodamage of the cells was dependent on the accumulation of
protoporphyrin. The decrease of the accumulation of
protoporphyrin was observed in the cells treated with inducers of
heme oxygenase (HO)-1. The ALA-dependent accumulation of
protoporphyrin was decreased in HeLa cells by transfection with HO-1 and HO-2
cDNA. Conversely, knockdown of HO-1/-2 with siRNAs enhanced the ALA-induced
protoporphyrin accumulation and photodamage. The ALA effect was decreased with HeLa cells expressing mitoferrin-2, a mitochondrial
iron transporter, whereas it was enhanced by the mitoferrin-2
siRNA transfection. These results indicated that not only the production of
porphyrin intermediates but also the reuse of
iron from
heme and mitochondrial
iron utilization control the ALA-induced accumulation of
protoporphyrin in cancerous cells.